Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Braxia Scientific Corp (BRAX.CN)

Braxia Scientific Corp (BRAX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,416
  • Shares Outstanding, K 283,280
  • Annual Sales, $ 1,884 K
  • Annual Income, $ -13,142 K
  • 60-Month Beta 1.72
  • Price/Sales 0.59
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BRAX.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $0.00 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0050 unch
on 04/23/24
0.0100 -50.00%
on 04/18/24
unch (unch)
since 03/22/24
3-Month
0.0050 unch
on 04/23/24
0.0100 -50.00%
on 04/18/24
-0.0050 (-50.00%)
since 01/23/24
52-Week
0.0050 unch
on 04/23/24
0.0300 -83.33%
on 06/09/23
-0.0200 (-80.00%)
since 04/21/23

Most Recent Stories

More News
Braxia Scientific Reports Q3 2024 Financial Results

Toronto, Ontario--(Newsfile Corp. - February 29, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research company with clinics...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Reports Mandatory Conversion of Debentures

Toronto, Ontario--(Newsfile Corp. - January 15, 2024) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research company with clinics...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - November 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research company with clinics...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Reports Q1 Fiscal 2024 Financial Results

Toronto, Ontario--(Newsfile Corp. - August 30, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia Scientific", or the "Company"), a medical research and telemedicine company...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Reports Fiscal 2023 Financial Results

Braxia Health ketamine treatments up 26% YoY in 2023 and revenue up 27% YoYCompany completes dosing of final participant in Phase 2, multi-dose Psilocybin trial, results expected to be published prior...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
RETRANSMISSION: Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Company Taking Strategic Actions to Prioritize Clinic Expansion, Enhance Operational Effectiveness and Right Size Cost StructureThis release adds information to the press release disseminated on June 9,...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic

Company Taking Strategic Actions to Prioritize Clinic Expansion, Enhance Operational Effectiveness and Right Size Cost StructureToronto, Ontario--(Newsfile Corp. - June 9, 2023) - Braxia Scientific Corp....

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine and Psychedelics Clinical IP

Toronto, Ontario--(Newsfile Corp. - March 16, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC PINK: BRAXF) (FWB: 4960) ("Braxia", or the "Company"), a medical research and telemedicine company with clinics...

BRAXF : 0.0060 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals

Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoYToronto, Ontario--(Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia...

IWINF : 0.2468 (-31.44%)
BRAXF : 0.0060 (unch)
IWIN.CN : 0.1400 (unch)
BRAX.CN : 0.0050 (unch)
Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement

Toronto, Ontario--(Newsfile Corp. - February 27, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960) ("Braxia", or the "Company"), a medical research company providing psychiatric,...

BRAX.CN : 0.0050 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders,...

See More

Key Turning Points

3rd Resistance Point 0.0050
2nd Resistance Point 0.0050
1st Resistance Point 0.0050
Last Price 0.0050
1st Support Level 0.0050
2nd Support Level 0.0050
3rd Support Level 0.0050

See More

52-Week High 0.0300
Fibonacci 61.8% 0.0204
Fibonacci 50% 0.0175
Fibonacci 38.2% 0.0145
Last Price 0.0050
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar